ASH 2022 Conference Coverage
Playback speed
10 seconds
ASH 2022 Preclinical In Vivo Activity of the Menin Inhibitor Ziftomenib (KO-539) in Pediatric KMT2A-Rearranged ALL
By
ASH 2022 Conference Coverage
FEATURING
Sarah Tasian
By
ASH 2022 Conference Coverage
FEATURING
Sarah Tasian
57 views
December 22, 2022
Login to view comments.
Click here to Login
Leukemia